David Gloss

10.5k total citations · 5 hit papers
57 papers, 6.5k citations indexed

About

David Gloss is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, David Gloss has authored 57 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Psychiatry and Mental health, 16 papers in Pediatrics, Perinatology and Child Health and 14 papers in Cellular and Molecular Neuroscience. Recurrent topics in David Gloss's work include Epilepsy research and treatment (24 papers), Neuroscience and Neuropharmacology Research (12 papers) and Pharmacological Effects and Toxicity Studies (12 papers). David Gloss is often cited by papers focused on Epilepsy research and treatment (24 papers), Neuroscience and Neuropharmacology Research (12 papers) and Pharmacological Effects and Toxicity Studies (12 papers). David Gloss collaborates with scholars based in United States, Canada and United Kingdom. David Gloss's co-authors include Gary Gronseth, Melissa J. Armstrong, Tamara Pringsheim, Alexander Rae‐Grant, Cynthia L. Harden, James C. Stevens, Gregory S. Day, Ronald C. Petersen, Thomas S.D. Getchius and Mary Ganguli and has published in prestigious journals such as JAMA, Neurology and Cochrane Database of Systematic Reviews.

In The Last Decade

David Gloss

57 papers receiving 6.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Practice guideline update summary: Mild cognitive impairment [RETIRED]

2017 1.4k citations Ronald C. Petersen, Oscar L. López et al. Neurology profile →
Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society

2016 764 citations David Gloss, Ravindra Arya et al. Epiliepsy currents profile →
Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache [RETIRED]

2016 436 citations Gary Gronseth, Melissa J. Armstrong et al. Neurology profile →
Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factors

2017 385 citations Cynthia L. Harden, David Gloss et al. Neurology profile →
Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders [RETIRED]

2014 378 citations Gary Gronseth, David Gloss et al. Neurology profile →

Peers

Countries citing papers authored by David Gloss

Since Specialization

Citations

This map shows the geographic impact of David Gloss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Gloss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Gloss more than expected).

Fields of papers citing papers by David Gloss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Gloss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Gloss. The network helps show where David Gloss may publish in the future.

Co-authorship network of co-authors of David Gloss

This figure shows the co-authorship network connecting the top 25 collaborators of David Gloss. A scholar is included among the top collaborators of David Gloss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Gloss. David Gloss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	How do network meta-analyses address intransitivity when assessing certainty of evidence: a systematic survey 2023 ·BMJ Open ·Ying Wang, (unknown), Tina Poklepović Peričić, Geertruida E Bekkering, Liangying Hou, Małgorzata M Bała, Ya Gao, Michael Wu, David Gloss, Reed Siemieniuk, Yutong Fei, Bram Rochwerg, Gordon Guyatt, Romina Brignardello‐Petersen	1
2	Genetic testing for the epilepsies: A systematic review 2021 ·Epilepsia ·Beth Rosen Sheidley, Jennifer Malinowski, Amanda L. Bergner, Louise Bier, David Gloss, Weiyi Mu, (unknown), (unknown), Annapurna Poduri	67
3	Minimum standards for inpatient long-term video-EEG monitoring: A clinical practice guideline of the international league against epilepsy and international federation of clinical neurophysiology 2021 ·Clinical Neurophysiology ·William O. Tatum, Jayanti Mani, Kazutaka Jin, Jonathan J. Halford, David Gloss, Firas Fahoum, Louis Maillard, Ian Mothersill, Sándor Beniczky	36
4	Practice Guideline: Use of Quantitative EEG for the Diagnosis of Mild Traumatic Brain Injury: Report of the Guideline Committee of the American Clinical Neurophysiology Society 2021 ·Journal of Clinical Neurophysiology ·Jeffrey R. Tenney, David Gloss, Ravindra Arya, Peter W. Kaplan, Ronald P. Lesser, (unknown), Marc R. Nuwer	11
5	Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee 2020 ·Epiliepsy currents ·David G. Vossler, Jacquelyn Bainbridge, Jane Boggs, Edward J. Novotny, Tobias Loddenkemper, Edward Faught, Marta Amengual‐Gual, (unknown), David Gloss, Donald M. Olson, Alan R. Towne, Dean K. Naritoku, Timothy E. Welty	68
6	Practice guideline update summary: Acute treatment of migraine in children and adolescents 2019 ·Neurology ·Maryam Oskoui, Tamara Pringsheim, Yolanda Holler‐Managan, Sonja Potrebic, Lori Billinghurst, David Gloss, Andrew D. Hershey, (unknown), Michael Sowell, M. Cristina Victorio, Elaine Gersz, (unknown), (unknown), Marcy Yonker, Kenneth J. Mack	101
7	Clinical utility of EEG in diagnosing and monitoring epilepsy in adults 2018 ·Clinical Neurophysiology ·William O. Tatum, Guido Rubboli, Peter W. Kaplan, (unknown), (unknown), David Gloss, Luís Otávio Sales Ferreira Caboclo, Frank W. Drislane, Michalis Koutroumanidis, Donald L. Schomer, Dorothée Kasteleijn‐Nolst Trenité, Mark Cook, Sándor Beniczky	190
8	Reporting bias in completed epilepsy intervention trials: A cross-sectional analysis 2018 ·Epilepsy Research ·(unknown), Stephanie Thompson, David Gloss, Konark Malhotra	3
9	Cannabinoids in treatment-resistant epilepsy: A review 2017 ·Epilepsy & Behavior ·Brooke K. O’Connell, David Gloss, Orrin Devinsky	158
10	Utilizing Bi-Spectral Index (BIS) for the monitoring of sedated adult ICU patients: a systematic review 2017 ·Minerva Anestesiologica ·Beliz Bilgili, (unknown), A. Joseph Layon, Andrea Berger, H. Lester Kirchner, (unknown), David Gloss	13
11	Practice guideline update summary: Mild cognitive impairment [RETIRED] breakdown → 2017 ·Neurology ·Ronald C. Petersen, Oscar L. López, Melissa J. Armstrong, Thomas S.D. Getchius, Mary Ganguli, David Gloss, Gary Gronseth, Daniel Marson, Tamara Pringsheim, Gregory S. Day, Mark A. Sager, James C. Stevens, Alexander Rae‐Grant	1431
12	Managing an Unprovoked First Seizure in Adults 2016 ·CNS Drugs ·David Gloss, Allan Krumholz	3
13	Practice guideline summary: Treatment of restless legs syndrome in adults [RETIRED] 2016 ·Neurology ·John W. Winkelman, Melissa J. Armstrong, Richard P. Allen, К. Ray Chaudhuri, William G. Ondo, Claudia Trenkwalder, Phyllis C. Zee, Gary Gronseth, David Gloss, Theresa Zesiewicz	152
14	An Overview of Products and Bias in Research 2015 ·Neurotherapeutics ·David Gloss	41
15	Epileptogenesis in the developing brain 2013 ·Handbook of clinical neurology ·Claude G. Wasterlain, David Gloss, Jérôme Niquet, Amy S. Wasterlain	12
16	Evidence-based guideline update: Vagus nerve stimulation for the treatment of epilepsy 2013 ·Neurology ·George L. Morris, David Gloss, Jeffrey Buchhalter, Kenneth J. Mack, Katherine Nickels, Cynthia L. Harden	281
17	Cannabinoids for epilepsy 2012 ·Cochrane Database of Systematic Reviews ·David Gloss, Barbara G. Vickrey	31
18	Recurrent lymphocytic hypophysitis and bilateral intracavernous carotid artery occlusion. An observation and review of the literature 2006 ·Neurological Research ·Miguel Melgar, Nitin R. Mariwalla, David Gloss, John W. Walsh	13
19	Postischemic Reperfusion: Ultrastructural Blood-Brain Barrier and Hemodynamic Correlative Changes in an Awake Model of Transient Forebrain Ischemia 2005 ·Neurosurgery ·Miguel Melgar, José A. Rafols, David Gloss, Fernando G. Díaz	29
20	Use of a Test of Psychomotor Ability in an Expanded Role 1981 ·Perceptual and Motor Skills ·David Gloss, (unknown)	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact